Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acetaminophen Panel To Mull Expanded Dosing, Standard Solid Concentration

This article was originally published in The Tan Sheet

Executive Summary

FDA is asking a joint advisory panel to consider whether it should restrict firms to one standard acetaminophen concentration for all solid oral dosage single-ingredient pediatric products, among other measures to reduce dosing errors.
Advertisement

Related Content

OTC Survey Underscores Label Communication Challenges
McNeil Recalls Liquid Infants’ Tylenol With Dosing Device Problem
Pediatric Acetaminophen Panel Debates Execution Of Dosing Changes
Pediatric Acetaminophen Panel Debates Execution Of Dosing Changes
OTC Industry Standardizes Pediatric Liquid Acetaminophen Concentration
FDA Advisory Panel To Evaluate Acetaminophen Pediatric Dosing
FDA Advisory Panel To Evaluate Acetaminophen Pediatric Dosing
Lower Acetaminophen Doses Recommended Despite Cost Impact, Lack Of Data
Advertisement
UsernamePublicRestriction

Register

PS105044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel